Overview

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Status:
Terminated
Trial end date:
2020-06-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability, and determine the maximum tolerated dose of INCB062079 in subjects with advanced hepatocellular carcinoma and other malignancies.
Phase:
Phase 1
Details
Lead Sponsor:
Incyte Corporation